PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.87%
Revenue growth at 75-90% of MAXN's 15.70%. Bill Ackman would push for innovation or market expansion to catch up.
29.38%
Gross profit growth under 50% of MAXN's 59.96%. Michael Burry would be concerned about a severe competitive disadvantage.
510.02%
EBIT growth above 1.5x MAXN's 22.39%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
150.57%
Operating income growth above 1.5x MAXN's 22.39%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
314.88%
Net income growth above 1.5x MAXN's 49.17%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
316.67%
EPS growth above 1.5x MAXN's 49.30%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
300.00%
Diluted EPS growth above 1.5x MAXN's 49.30%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.10%
Share reduction more than 1.5x MAXN's 0.24%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
10.66%
Diluted share count expanding well above MAXN's 0.24%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
90.53%
Positive OCF growth while MAXN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
68.62%
Positive FCF growth while MAXN is negative. John Neff would see a strong competitive edge in net cash generation.
-49.92%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-21.54%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-18.17%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
88.61%
Positive long-term OCF/share growth while MAXN is negative. John Neff would see a structural advantage in sustained cash generation.
84.07%
Positive OCF/share growth while MAXN is negative. John Neff might see a comparative advantage in operational cash viability.
88.00%
Positive 3Y OCF/share CAGR while MAXN is negative. John Neff might see a big short-term edge in operational efficiency.
290.88%
Net income/share CAGR above 1.5x MAXN's 9.86% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
300.31%
5Y net income/share CAGR above 1.5x MAXN's 9.86%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
839.36%
3Y net income/share CAGR above 1.5x MAXN's 9.86%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-65.99%
Negative equity/share CAGR over 10 years while MAXN stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-36.42%
Negative 5Y equity/share growth while MAXN is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
373.90%
Equity/share CAGR of 373.90% while MAXN is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.10%
AR growth is negative/stable vs. MAXN's 90.60%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
2.57%
Inventory growth well above MAXN's 0.99%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
11.78%
Asset growth at 50-75% of MAXN's 16.23%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
35.07%
Positive BV/share change while MAXN is negative. John Neff sees a clear edge over a competitor losing equity.
-5.16%
We’re deleveraging while MAXN stands at 72.96%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-8.39%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-6.36%
We cut SG&A while MAXN invests at 35.42%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.